Raw-data of CYTOF of PBMC from AITL patients

Published: 16 May 2025| Version 1 | DOI: 10.17632/fwnrfccs8m.1
Contributor:
yj ru

Description

Angioimmunoblastic T-cell lymphoma (AITL), an aggressive T-cell malignancy derived from follicular helper T (Tfh) cells, is characterized by systemic immune dysregulation and heterogeneous clinical outcomes despite anthracycline-based chemotherapy. Here, we perform Cytof in PBCM of AITL patients to describe peripheral immune landscapes of AITL.

Files

Categories

T-Cell Lymphoma

Licence